You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP)
|
|---|---|
| Published in |
Frontiers in immunology, March 2020
|
| DOI | 10.3389/fimmu.2020.00524 |
| Pubmed ID | |
| Authors |
Robert David Sandler, Rachel Scarlett Tattersall, Helene Schoemans, Raffaella Greco, Manuela Badoglio, Myriam Labopin, Tobias Alexander, Kirill Kirgizov, Montserrat Rovira, Muhammad Saif, Riccardo Saccardi, Julio Delgado, Zinaida Peric, Christian Koenecke, Olaf Penack, Grzegorz Basak, John Andrew Snowden |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Italy | 2 | 13% |
| United Kingdom | 2 | 13% |
| United States | 2 | 13% |
| Russia | 1 | 7% |
| Croatia | 1 | 7% |
| Iran, Islamic Republic of | 1 | 7% |
| Morocco | 1 | 7% |
| Spain | 1 | 7% |
| Thailand | 1 | 7% |
| Other | 0 | 0% |
| Unknown | 3 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 10 | 67% |
| Practitioners (doctors, other healthcare professionals) | 2 | 13% |
| Scientists | 1 | 7% |
| Science communicators (journalists, bloggers, editors) | 1 | 7% |
| Unknown | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 107 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 107 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 16 | 15% |
| Student > Master | 12 | 11% |
| Researcher | 11 | 10% |
| Student > Postgraduate | 6 | 6% |
| Student > Bachelor | 6 | 6% |
| Other | 15 | 14% |
| Unknown | 41 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 37 | 35% |
| Biochemistry, Genetics and Molecular Biology | 9 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
| Business, Management and Accounting | 3 | 3% |
| Unspecified | 3 | 3% |
| Other | 8 | 7% |
| Unknown | 43 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2022.
All research outputs
#4,230,203
of 25,611,630 outputs
Outputs from Frontiers in immunology
#4,583
of 32,048 outputs
Outputs of similar age
#91,990
of 397,383 outputs
Outputs of similar age from Frontiers in immunology
#120
of 625 outputs
Altmetric has tracked 25,611,630 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,048 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 397,383 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 625 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.